Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula

Get In Touch

Quick Email
info.help@gmail.com
  • Home |
  • AstraZeneca scraps FLAP inhibitor after flunking phase 2 asthma trial

AstraZeneca scraps FLAP inhibitor after flunking phase 2 asthma trial

  • April 29, 2026

AstraZeneca has scrapped an asthma program after the FLAP inhibitor flunked a phase 2 trial.

Leave A Comment

Fields (*) Mark are Required